Oxford Biomedica plc (LON: OXB)

Market Cap	442.51M
Revenue (ttm)	97.28M
Net Income (ttm)	-142.02M
Shares Out	105.36M
EPS (ttm)	-1.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,118
Open	402.50
Previous Close	412.50
Day's Range	398.80 - 422.00
52-Week Range	164.29 - 450.00
Beta	1.09
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and de...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 703
• Stock Exchange: London Stock Exchange
• Ticker Symbol: OXB

Financial Performance

In 2023, Oxford Biomedica's revenue was 89.54 million, a decrease of -36.04% compared to the previous year's 139.99 million. Losses were -157.49 million, 302.2% more than in 2022.